Growth Metrics

Forte Biosciences (FBRX) Total Liabilities (2016 - 2020)

Historic Total Liabilities for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $2.4 million.

  • Forte Biosciences' Total Liabilities fell 9526.78% to $2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.4 million, marking a year-over-year decrease of 9526.78%. This contributed to the annual value of $17.3 million for FY2019, which is 6147.41% down from last year.
  • As of Q3 2020, Forte Biosciences' Total Liabilities stood at $2.4 million, which was down 9526.78% from $3.4 million recorded in Q2 2020.
  • Over the past 5 years, Forte Biosciences' Total Liabilities peaked at $50.9 million during Q3 2019, and registered a low of $2.4 million during Q3 2020.
  • Its 5-year average for Total Liabilities is $29.2 million, with a median of $25.3 million in 2016.
  • As far as peak fluctuations go, Forte Biosciences' Total Liabilities surged by 16165.47% in 2019, and later crashed by 9526.78% in 2020.
  • Forte Biosciences' Total Liabilities (Quarter) stood at $28.4 million in 2016, then decreased by 25.97% to $21.0 million in 2017, then skyrocketed by 114.07% to $44.9 million in 2018, then tumbled by 61.47% to $17.3 million in 2019, then plummeted by 86.07% to $2.4 million in 2020.
  • Its Total Liabilities stands at $2.4 million for Q3 2020, versus $3.4 million for Q2 2020 and $16.6 million for Q1 2020.